Thrombocytopenia Prevention
Researchers from University of Texas, M. D. Anderson Cancer Center describe findings in thrombocytopenia prevention
Published in Blood Weekly, October 16th, 2008
A new study, 'The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia,' is now available. "During therapy with tyrosine kinase inhibitors (TKIs), approximately 20% to 50% of patients with chronic myeloid leukemia (CML) develop grade >or=3 thrombocytopenia leading to treatment interruptions and dose reductions. Interleukin 11 (IL-11) reduces the incidence and the severity of thrombocytopenia in solid tumors," scientists writing in the journal Cancer report.
"The authors investigated the efficacy and safety of low-dose IL-11 for improving thrombocytopenia associated with TKI...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-10-16)
More Articles from Blood Weekly
- Universidad de Granada
Scientists identify the genes that cause blindness produced by corneal edema - Whitehead Institute for Biomedical Research
Short RNAs show a long history - World Journal of Gastroenterology
What is the role of interleukin-10 in ischemia-reperfusion injury? - AngioDynamics, Inc.
AngioDynamics Reports Financial Results for Fiscal First Quarter 2009 - Cancer
Research results from University of California update knowledge of cancer - Colon Cancer
Breakthrough Optical Technology To Assess Colon Cancer Risk, Accuracy - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
